Elevated intragraft expression of innate immunity and cell death-related markers is a risk factor for adverse graft outcome

Author(s):
Yang, J.X.; Snijders, M.L.H.; Haasnoot, G.W.; Kooten, C. van (0000-0002-6257-0899); Mallat, M.; Fijter, J.W. de; Clahsen-van Groningen, M.C.; Claas, F.H.J. (0000-0003-4157-6201); Eikmans, M.
Published
2018
Publication type
Article / Letter to editor
Toll like receptorsComplementApoptosisGene expressionKidney transplant outcome
Date issued
2018-06-30
Language
English
Is part of
Transplant Immunology (2018), Vol. 48, p. 39-46
hdl
1887/96166
doi
10.1016/j.trim.2018.02.009